The efficacy and safety of the low-thalidomide dose CTD (cyclophosphamide, thalidomide, dexamethasone) regimen in patients with multiple myeloma--a report by the Polish Myeloma Study Group. (Q42971621)
Jump to navigation
Jump to search
scientific article published on 2 June 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | The efficacy and safety of the low-thalidomide dose CTD (cyclophosphamide, thalidomide, dexamethasone) regimen in patients with multiple myeloma--a report by the Polish Myeloma Study Group. |
scientific article published on 2 June 2010 |
Statements
The efficacy and safety of the low-thalidomide dose CTD (cyclophosphamide, thalidomide, dexamethasone) regimen in patients with multiple myeloma--a report by the Polish Myeloma Study Group (English)
Anna Dmoszynska
Wieslaw Wiktor Jedrzejczak
Aleksander Skotnicki
Grzegorz Charlinski
Janusz Kloczko
Adam Walter-Croneck
Lidia Usnarska-Zubkiewicz
Joanna Manko
Teresa Wolska-Smolen